Hematopoietic Stem-Cell Transplantation versus Immunosuppressive Therapy in Patients with Adult Acquired Severe Aplastic Anemia: A Cost-Effectiveness Analysis-Reference-Cited by-同舟云学术

Hematopoietic Stem-Cell Transplantation versus Immunosuppressive Therapy in Patients with Adult Acquired Severe Aplastic Anemia: A Cost-Effectiveness Analysis

Published:2021-07 Issue: Volume:Volume 14 Page:3529-3537
ISSN:1178-7074
Container-title:International Journal of General Medicine
language:en
Short-container-title:IJGM

Author:

Zhang Meng-Xue,Wang Qian,Wang Xiao-Qin

Publisher

Informa UK Limited

Subject

General Medicine

Reference32 articles.

1. Aplastic Anemia

2. Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors

3. Aplastic Anemia: First-line Treatment by Immunosuppression and Sibling Marrow Transplantation

5. Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study;Bone Marrow Transplantation;2024-08-01

2. Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT;Blood;2024-07-18

3. The long-term outcomes and safety of severe aplastic anemia treated with porcine antilymphocyte globulin plus cyclosporine, with or without thrombopoietin receptor agonists: a double-center retrospective study;Expert Review of Hematology;2024-05-03

4. Ibrutinib versus bendamustine plus rituximab for first-line treatment of 65 or older patients with untreated chronic lymphocytic leukemia without del(17p)/TP53 mutation in China: a lifetime economic research study;BMC Health Services Research;2023-12-05

5. The long-term outcome and safety of severe aplastic anemia treated with porcine antilymphocyte globulin plus cyclosporine, with or without thrombopoietin receptor agonists: a double-center retrospective study;2023-10-17